Anesthesia, IntravenousAnesthetics, IntravenousMethohexitalPropofolThiopentalAntineoplastic Combined Chemotherapy ProtocolsCardiac OutputRadiation DosageChemotherapy, AdjuvantRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationCombined Modality TherapyRadiation ToleranceAntineoplastic AgentsRadiationEnzyme InductionCisplatinTreatment OutcomeRadiation MonitoringRadiation ProtectionDoxorubicinCyclophosphamideBreast NeoplasmsRadiotherapyDisease-Free SurvivalDrug Administration ScheduleNeoadjuvant TherapyTime FactorsRadiotherapy DosageNeoplasm StagingSurvival AnalysisEtoposideRadiation OncologySurvival RatePrognosisInduction ChemotherapyNeoplasmsLung NeoplasmsRadiation Injuries, ExperimentalRadiation PneumonitisGamma RaysNeoplasms, Radiation-InducedCosmic RadiationRadiometryNeoplasm Recurrence, LocalMethotrexatePaclitaxelCarboplatinApoptosisRadiotherapy, AdjuvantCell Line, TumorVinblastineUltraviolet RaysTaxoidsFollow-Up StudiesDose FractionationDrug Resistance, NeoplasmBleomycinBackground RadiationAntimetabolites, AntineoplasticDeoxycytidineIfosfamideAdenocarcinomaBrain NeoplasmsRadiation-Sensitizing AgentsAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungRNA, MessengerDose-Response Relationship, DrugOrganoplatinum CompoundsCytarabineRadiation EffectsNeoplasm MetastasisAntineoplastic Agents, PhytogenicSalvage TherapyCells, CulturedRadiation-Protective AgentsCell SurvivalProspective StudiesDNA DamageHodgkin DiseaseAnthracyclinesTumor Cells, CulturedSignal TransductionLymphoma, Non-HodgkinOvarian NeoplasmsCarcinoma, Squamous CellVomitingNeutropeniaClinical Trials as TopicInfusions, IntravenousRadiotherapy, Intensity-ModulatedHead and Neck NeoplasmsAntibiotics, AntineoplasticDacarbazineNauseaCell LineTransplantation, AutologousAntibodies, Monoclonal